Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Association between serum chloride levels with mortality in critically ill patients with acute kidney injury: An observational multicenter study employing the eICU database

  • Xu Zhu,

    Roles Data curation, Formal analysis

    Affiliation Department of Epidemiology and Health Statistics, College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China

  • Jing Xue,

    Roles Formal analysis

    Affiliation Department of Scientific Research, Xiangya Hospital, Central South University, Changsha, Hunan, China

  • Zheng Liu,

    Roles Writing – original draft

    Affiliation Department of Anesthesiology, Shandong Provincial Qianfoshan Hospital, The First Hospital Affiliated with Shandong First Medical University, Ji’nan, Shandong, China

  • Wenjie Dai,

    Roles Writing – review & editing

    Affiliation Xiangya School of Public Health, Central South University, Changsha, Hunan, China

  • Jingsha Xiang,

    Roles Writing – original draft

    Affiliation Xiangya School of Public Health, Central South University, Changsha, Hunan, China

  • Hui Xu,

    Roles Writing – review & editing

    Affiliation Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China

  • Qiaoling Zhou,

    Roles Writing – review & editing

    Affiliation Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China

  • Quan Zhou,

    Roles Writing – review & editing

    Affiliation Department of Science and Education, The First People’s Hospital of Changde City, Changde, Hunan, China

  • Wenhang Chen

    Roles Conceptualization, Writing – original draft

    wenhangchen@csu.edu.cn

    Affiliations Department of Nephrology, Xiangya Hospital, Central South University, Changsha, Hunan, China, Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University, Changsha, Hunan, China

Abstract

Objective

The effect of the serum chloride (Cl) level on mortality in critically ill patients with acute kidney injury (AKI) remains unknown. We sought an association between mortality and serum Cl.

Methods

We identified AKI patients in the eICU Collaborative Research Database from 2014 to 2015 at 208 US hospitals. The outcomes included in-hospital and intensive care unit (ICU) mortality. Time-varying covariates Cox regression models and the Kaplan-Meier (K-M) curves were used to assess the association between serum Cl levels and mortality. Multivariable adjusted restricted cubic spline models were used to analyze the potential nonlinear relationship between mortality and serum Cl.

Results

In total, 4,234 AKI patients were included in the study. Compared with normochloremia (98≤chloride<108mEq/L), hypochloremia (Cl<98mEq/L) was associated with mortality (adjusted hazard ratio [HR] for in-hospital mortality 1.46, 95% confidence interval [CI] 1.20–1.80, P = 0.0003; adjusted HR for ICU mortality 1.37, 95% CI 1.05–1.80, P = 0.0187). Hyperchloremia showed no significant difference in mortality compared to normochloremia (adjusted HR for in-hospital mortality 0.89, 95% CI 0.76–1.04, P = 0.1438; adjusted HR for ICU mortality 0.87, 95% CI 0.72–1.06, P = 0.1712). Smoothing curves revealed continuous non-linear associations between serum Cl levels and mortality. The K-M curve showed that patients with hypochloremia presented with a lower survival rate.

Conclusions

Lower serum Cl levels after ICU admission was associated with increased in-hospital and ICU mortality in critically ill patients with AKI. The results should be verified in well-designed prospective studies.

Introduction

Acute kidney injury (AKI) is manifested by an elevated serum creatinine level and/or decreased urine output attributable to abrupt deterioration in kidney function [1]. AKI is associated with an increased risk of later chronic kidney disease (CKD), end-stage renal disease, cardiovascular events, and in-hospital and long-term mortality [2, 3]. Many patients, especially patients in intensive care units (ICUs), are at risk of AKI [46].

Chloride (Cl) is the principal extracellular anion in the human body; it contributes approximately one-third of all extracellular fluid tonicity. Serum Cl exerts many physiological functions including maintenance of the osmotic and acid–base balance, body fluid distribution, and muscular activity [7]. The kidneys are important regulators of Cl homeostasis. Renal tubular Cl re-absorption is critical in terms of extracellular fluid volume maintenance [8]. Dyschloremia (both hypochloremia and hyperchloremia) is common in critically ill patients; it is attributable to various etiological factors or treatments [7]. Dyschloremia has also been associated with worse outcomes among patients in ICUs or coronary care units [911]. Importantly, dyschloremia is an independent prognostic predictor of hypertensive patients [12], decompensated cirrhosis [13], chronic heart failure [14], and CKD [15], as well as pediatric patients [16]. The causal link between hyperchloremia and the risk of AKI has yet to be proven [1719]. In critically ill patients, hypochloremia is associated with an increased risk of development of AKI [20]. However, the impact of the serum Cl level on clinical outcomes in patients with AKI remains poorly characterized. Here, we explored the association between the serum Cl level and the risk of mortality in critically ill AKI patients.

Materials and methods

Data source

This retrospective observational study used data from the eICU Collaborative Research Database (eICU-CRD) ver. 2.0, which constitutes a large, publicly available multicenter database regarding 200,859 ICU admissions of 139,367 patients from 2014 to 2015 at 208 US hospitals [21]. The eICU database is de-identified but contains comprehensive records, including demographics, physiological readings from bedside monitors, diagnoses, treatment information, and other clinical data collected during routine medical care. The use of the database was approved by the Institutional Review Board (IRB) of the Massachusetts Institute of Technology (Cambridge, MA, USA). Xu Zhu, an author of this study, completed the “Protecting Human Research Participants” curriculum and then accessed the eICU-CRD data (authorization code 41711250). The study was approved by the Institutional Review Board of the Xiangya Hospital of Central South University. All methods were carried out in accordance with relevant guidelines and regulations. The results are reported in accordance with the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) Statement [22].

Selection criteria

Patients with acute renal failure were potentially eligible. The exclusion criteria were: not the first ICU admission in the database; ICU length of stay (LOS) < 24 h; age < 18 years; loss of > 5% of all data; missing serum Cl data within 72 h after ICU admission; missing LOS data, and the absence of survival outcomes including in-hospital or ICU mortality.

Data collection

PostgreSQL (ver. 9.6) was used to extract all variables and outcomes in Structured Query Language (SQL) format. Demographic information included age, sex, ethnicity, weight and height on admission. Comorbidities included sepsis, CKD, hypertension, heart failure, coronary artery disease, diabetes, pneumonia. Laboratory parameters included the levels of sodium, potassium, magnesium, total calcium, phosphate, bicarbonate, albumin, creatinine, and blood urea nitrogen. Laboratory parameters were obtained within 72 h after ICU admission. The first laboratory value (except the value of Cl) was included if there were multiple values. The APACHE IV score was extracted to assess illness. In terms of treatments, the following data were extracted: use of antibiotics, diuretics, and vasopressors, as well as mechanical ventilation statuses. AKI was staged in accordance with the Kidney Disease: Improving Global Outcomes guidelines [23]. Survival statuses at hospital and ICU discharge were recorded.

Endpoints

The primary outcome was all-cause in-hospital mortality (i.e., survival at hospital discharge). ICU mortality, defined as survival at ICU discharge, was considered a secondary outcome.

Statistical analysis

Participants were groups as follows: normochloremia (98≤Cl<108mEq/L), hypochloremia (Cl<98mEq/L) and hyperchloremia (Cl≥108mEq/L). Normal serum Cl was used as the reference category. If variables were normally distributed and the variance was homogeneous, the data are expressed as means ± standard deviations; they were compared between groups using Student’s t-test. Otherwise, the data are presented as medians with interquartile ranges, and the Wilcoxon rank-sum test was used for between-group comparisons of such variables. Categorical variables are expressed as numbers with proportions; between-group comparisons of such variables were made using the chi-squared test or Fisher’s exact test (as appropriate). Time-varying covariates Cox regression models were used to estimate the hazard ratios (HRs) for associations between Cl levels and outcomes in both univariate and multivariate analyses [24]. Two multivariate models were constructed based on the adjusted variables. Model I adjusted for age, sex, and ethnicity; model II adjusted for variables in model I, along with weight and height on admission, comorbidities, laboratory data, and treatment. We explored the potential nonlinear relationship between serum Cl levels and mortality by using multivariable adjusted restricted cubic spline models [25]. Kaplan-Meier curves were plotted to calculate the cumulative survival rates according to serum Cl categories [26]. Their differences were analyzed by the log-rank test. A two-tailed p-value < 0.05 was considered statistically significant. All statistical analyses were performed using R software (ver. 4.1.2; R Foundation for Statistical Computing, Vienna, Austria) and Empower (R) (X & Y Solutions, Inc., Boston, MA, USA).

Results

Patient characteristics

Data regarding 19,781 AKI patients were initially obtained from the eICU database; of these patients, 4,234 were included in the analysis (Fig 1). Their general characteristics are presented in Table 1. The mean age was 65.78 years and 2,414 (57.01%) patients were male. Most patients were Caucasian (72.32%). The leading comorbidity was sepsis (38.14%). Of all patients, 48.82% required mechanical ventilation and 12.87% patients were treated with diuretics.

thumbnail
Fig 1. Flowchart of included patients.

Abbreviations: AKI, acute kidney injury; ICU, intensive care unit.

https://doi.org/10.1371/journal.pone.0273283.g001

thumbnail
Table 1. Baseline clinical and laboratory characteristics of the study patients.

https://doi.org/10.1371/journal.pone.0273283.t001

Associations between serum Cl and outcomes

In the time-varying covariates Cox regression modes, compared with normal serum Cl, hypochloremia had significantly higher risks of both in-hospital mortality and ICU mortality (adjusted HR 1.46, 95% CI 1.20–1.80, P = 0.0003; adjusted HR 1.37, 95% CI 1.05–1.80, P = 0.0187; respectively) (Table 2). Hyperchloremia was not significantly associated with in-hospital mortality and ICU mortality (adjusted HR 0.89, 95% CI 0.76–1.04, P = 0.1438; adjusted HR 0.87, 95% CI 0.72–1.06, P = 0.1712; respectively). As shown in Figs 2 and 3, we observed non-linear associations between serum Cl and in-hospital, ICU mortality (Pnon–linearity for in-hospital mortality = 0.0001; Pnon–linearity for ICU mortality = 0.0015). Fig 4 shows the Kaplan-Meier curve for in-hospital survival. The cumulative survival rate was significantly lower in the hypochloremia group compared with the normochloremia (Log rank P = 0.0071).

thumbnail
Fig 2. The smoothing curves of in-hospital mortality of critically ill AKI patients against serum chloride.

The solid red lines represent the effect estimates and the shaded area represents 95% confidence intervals. P for non–linearity = 0.0001. Abbreviations: AKI, acute kidney injury.

https://doi.org/10.1371/journal.pone.0273283.g002

thumbnail
Fig 3. The smoothing curves of ICU mortality of critically ill AKI patients against serum chloride.

The solid red lines represent the effect estimates and the shaded area represents 95% confidence intervals. P for non–linearity = 0.0015. Abbreviations: AKI, acute kidney injury; ICU, intensive care units.

https://doi.org/10.1371/journal.pone.0273283.g003

thumbnail
Fig 4. Kaplan-Meier survival curve for in-hospital mortality stratified by serum chloride in three groups.

Log rank p-values between groups were reported.

https://doi.org/10.1371/journal.pone.0273283.g004

thumbnail
Table 2. Associations of time-varying serum chloride with in-hospital and ICU mortality.

https://doi.org/10.1371/journal.pone.0273283.t002

Subgroup analyses

We performed subgroup analyses to assess the relationship between serum Cl and the in-hospital mortality risk (Table 3). Patients were categorized according to age (≤ 62 and > 62 years), sex, sepsis, heart failure, coronary artery disease, hypertension, CKD, diabetes, pneumonia, sodium and bicarbonate levels, the APACHE IV score, AKI stages, and diuretic usage. The association between hypochloremia and outcomes was consistently positive in different subgroups except CKD patients, patients with sodium ≥145 mmol/L, and patients received diuretic. The only significant interaction effects were bicarbonate values for in-hospital mortality (P for interaction = 0.0492) while no interaction effect for any subgroup was observed.

thumbnail
Table 3. Subgroup analysis for the effect of serum chloride on in-hospital mortality.

https://doi.org/10.1371/journal.pone.0273283.t003

Discussion

We found that lower serum Cl levels were associated with increased risk of in-hospital and ICU mortality in critically ill patients with AKI after adjusting for potential confounders and a detailed literature search confirmed that, this is the first study to investigate the association between serum Cl levels and mortality in critically ill patients with AKI.

The leading causes of hypochloremia in critically ill patients are a decreased intake or an increased loss of Cl. For example, hypochloremia may be triggered by loss of gastric fluid via vomiting or gastric drainage, water toxicity, excess infusion of hypotonic solutions, malnutrition, diuretic therapy or adrenal insufficiency, heart failure, or impaired renal Cl reabsorption [27]. Dyschloremia is common in critically ill patients and is associated with poor outcomes [28, 29]. Several studies identified hypochloremia as an independent negative prognostic marker in patients with CKD or chronic heart failure [14, 15, 3032]. Hypochloremia appeared to be independently associated with an increased risk of AKI. Patients with serum Cl levels ≤ 94 mEq/L had a significantly greater risk of AKI than did patients with Cl levels 100–108 mmol/L (odds ratio [OR] 1.7, 95% CI 1.1–2.6, P = 0.01) [20]. Kee et al. analyzed 483 ICU survivors with severe AKI requiring continuous renal replacement therapy; they found that patients with hypochloremia had a significantly higher risk of incomplete renal recovery than did a normochloremia group (OR 5.12, 95% CI 2.56–10.23, P < 0.001). Hypochloremia was also significantly associated with a higher risk of renal failure (OR 2.74, 95% CI 1.19–6.32, P = 0.02) [33].

We found that hypochloremia was independently prognostic of mortality in critically ill patients with AKI. This relationship has not previously been described; the mechanism is thus unknown. Hypochloremia might be a biomarker of a mortality risk or a direct contributor to the pathology leading to mortality. Serum sodium and Cl levels are presumably very highly correlated. Associations between serum sodium levels and adverse outcomes have been reported in elderly AKI patients, as well as ICU patients with AKI [34, 35]. The serum Cl level might be a surrogate of dysnatremia. However, our multivariate indicated that the prognostic utility of hypochloremia in terms of mortality was independent of the sodium level. In critically ill patients, Cl levels might decrease because of Cl loss in the gastrointestinal tract, excessive diuretic therapy, and malnutrition [7, 36]. AKI patients with hypochloremia likely experience hypovolemia attributable to reduced fluid and nutritional intakes. Because our work was retrospective observational study, we could not confirm any causal relationship between hypochloremia and mortality.

The large sample size (4,233 patients from 208 US hospitals) is a strength of our study. However, our work had several limitations. First, although we highlighted the prognostic utility of the serum Cl level in terms of mortality among AKI patients in ICUs, we could not explain the underlying mechanism. Second, we could not assess the effects of changes in serum Cl levels on prognosis. Third, the eICU database lacks information regarding the SCr levels during the 3 months prior to admission, as well as information regarding major adverse events after discharge. Thus, we could not estimate previous renal function or accurately define the AKI stages. The possible predictive utility of the serum Cl for renal, cerebrovascular and cardiovascular events, as well as its long-term predictive value, was not quantifiable. Fourth, selection bias may have been present, considering the retrospective nature of the work. The confounding factors were not equally distributed among the groups. Although multivariate Cox regression analyses were used to control for potential confounders, high-quality clinical trials are required to strengthen our results.

Conclusions

Lower serum Cl levels after ICU admission were associated with increased in-hospital and ICU mortality among critically ill patients with AKI. These results should be verified in well-designed prospective trials.

Acknowledgments

We would like to thank all the researchers who built and maintained the eICU database.

References

  1. 1. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. Journal of the American Society of Nephrology: JASN. 2009;20(3):672–9. pmid:19244578
  2. 2. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 2012;81(5):442–8. pmid:22113526
  3. 3. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961–73. pmid:19346042
  4. 4. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756–66. pmid:22617274
  5. 5. Lewington AJ, Cerdá J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013;84(3):457–67. pmid:23636171
  6. 6. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–6. pmid:11979336
  7. 7. Berend K, van Hulsteijn LH, Gans RO. Chloride: the queen of electrolytes? Eur J Intern Med. 2012;23(3):203–11. pmid:22385875
  8. 8. Hennings JC, Andrini O, Picard N, Paulais M, Huebner AK, Cayuqueo IK, et al. The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. Journal of the American Society of Nephrology: JASN. 2017;28(1):209–17. pmid:27335120
  9. 9. Breen TJ, Brueske B, Sidhu MS, Kashani KB, Anavekar NS, Barsness GW, et al. Abnormal serum chloride is associated with increased mortality among unselected cardiac intensive care unit patients. PloS one. 2021;16(4):e0250292. pmid:33901227
  10. 10. Boniatti MM, Cardoso PR, Castilho RK, Vieira SR. Is hyperchloremia associated with mortality in critically ill patients? A prospective cohort study. J Crit Care. 2011;26(2):175–9. pmid:20619601
  11. 11. Li Z, Xing C, Li T, Du L, Wang N. Hypochloremia is associated with increased risk of all-cause mortality in patients in the coronary care unit: A cohort study. The Journal of international medical research. 2020;48(4):300060520911500. pmid:32338101
  12. 12. McCallum L, Jeemon P, Hastie CE, Patel RK, Williamson C, Redzuan AM, et al. Serum chloride is an independent predictor of mortality in hypertensive patients. Hypertension. 2013;62(5):836–43. pmid:23980073
  13. 13. Sumarsono A, Wang J, Xie L, Chiang GC, Tielleman T, Messiah SE, et al. Prognostic Value of Hypochloremia in Critically Ill Patients With Decompensated Cirrhosis. Crit Care Med. 2020;48(11):e1054–e61. pmid:32947468
  14. 14. Cuthbert JJ, Pellicori P, Rigby A, Pan D, Kazmi S, Shah P, et al. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. Eur J Heart Fail. 2018;20(10):1426–35. pmid:29943886
  15. 15. Kubota K, Sakaguchi Y, Hamano T, Oka T, Yamaguchi S, Shimada K, et al. Prognostic value of hypochloremia versus hyponatremia among patients with chronic kidney disease-a retrospective cohort study. Nephrol Dial Transplant. 2020;35(6):987–94. pmid:30346587
  16. 16. Stenson EK, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Hyperchloremia Is Associated With Complicated Course and Mortality in Pediatric Patients With Septic Shock. Pediatr Crit Care Med. 2018;19(2):155–60. pmid:29394222
  17. 17. Suetrong B, Pisitsak C, Boyd JH, Russell JA, Walley KR. Hyperchloremia and moderate increase in serum chloride are associated with acute kidney injury in severe sepsis and septic shock patients. Critical care (London, England). 2016;20(1):315. pmid:27716310
  18. 18. Commereuc M, Nevoret C, Radermacher P, Katsahian S, Asfar P, Schortgen F. Hyperchloremia is not associated with AKI or death in septic shock patients: results of a post hoc analysis of the "HYPER2S" trial. Ann Intensive Care. 2019;9(1):95. pmid:31440853
  19. 19. Honore PM, Mugisha A, Kugener L, Redant S, Attou R, Gallerani A, et al. The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure. Critical care (London, England). 2020;24(1):271. pmid:32466768
  20. 20. Shao M, Li G, Sarvottam K, Wang S, Thongprayoon C, Dong Y, et al. Dyschloremia Is a Risk Factor for the Development of Acute Kidney Injury in Critically Ill Patients. PloS one. 2016;11(8):e0160322. pmid:27490461
  21. 21. Pollard TJ, Johnson AE, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Scientific data. 2018;5(1):1–13.
  22. 22. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. pmid:18064739
  23. 23. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al. The burden of kidney disease: improving global outcomes. Kidney Int. 2004;66(4):1310–4. pmid:15458424
  24. 24. Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CGM. Time-varying covariates and coefficients in Cox regression models. Ann Transl Med. 2018;6(7):121. pmid:29955581
  25. 25. Harrell FE Jr., Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. Journal of the National Cancer Institute. 1988;80(15):1198–202. pmid:3047407
  26. 26. Efron B. Logistic regression, survival analysis, and the Kaplan-Meier curve. Journal of the American statistical Association. 1988;83(402):414–25.
  27. 27. Bandak G, Kashani KB. Chloride in intensive care units: a key electrolyte. F1000Res. 2017;6:1930. pmid:29123653
  28. 28. Vandergheynst F, Sakr Y, Felleiter P, Hering R, Groeneveld J, Vanhems P, et al. Incidence and prognosis of dysnatraemia in critically ill patients: analysis of a large prevalence study. Eur J Clin Invest. 2013;43(9):933–48. pmid:23869476
  29. 29. Sakr Y, Rother S, Ferreira AM, Ewald C, Dünisch P, Riedemmann N, et al. Fluctuations in serum sodium level are associated with an increased risk of death in surgical ICU patients. Crit Care Med. 2013;41(1):133–42. pmid:23128383
  30. 30. Zhang Y, Peng R, Li X, Yu J, Chen X, Zhou Z. Serum chloride as a novel marker for adding prognostic information of mortality in chronic heart failure. Clin Chim Acta. 2018;483:112–8. pmid:29684381
  31. 31. Mandai S, Kanda E, Iimori S, Naito S, Noda Y, Kikuchi H, et al. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study. Clin Exp Nephrol. 2017;21(1):104–11. pmid:27039905
  32. 32. Testani JM, Hanberg JS, Arroyo JP, Brisco MA, Ter Maaten JM, Wilson FP, et al. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail. 2016;18(6):660–8. pmid:26763893
  33. 33. Kee YK, Jeon HJ, Oh J, Shin DH. Dyschloremia is associated with failure to restore renal function in survivors with acute kidney injury: an observation retrospective study. Scientific reports. 2020;10(1):19623. pmid:33184400
  34. 34. Gao XP, Zheng CF, Liao MQ, He H, Liu YH, Jing CX, et al. Admission serum sodium and potassium levels predict survival among critically ill patients with acute kidney injury: a cohort study. BMC nephrology. 2019;20(1):311. pmid:31395027
  35. 35. Li Q, Wang Y, Mao Z, Kang H, Zhou F. Serum Sodium Levels Predict Mortality in Elderly Acute Kidney Injury Patients: A Retrospective Observational Study. Int J Gen Med. 2021;14:603–12. pmid:33658833
  36. 36. Yunos NM, Bellomo R, Story D, Kellum J. Bench-to-bedside review: Chloride in critical illness. Critical care (London, England). 2010;14(4):226. pmid:20663180